Governments and healthcare organizations use healthy life expectancy as a key indicator to assess the effectiveness of health policies and interventions and to identify areas where improvements in public health are needed.

政府和医疗机构将健康预期寿命作为评估卫生政策和干预措施有效性的关键指标，并确定需要改善公共卫生的领域。

Two phase III clinical trials have offered conflicting results, and an independent advisory panel convened by the US Food and Drug Administration to assess the drug's effectiveness says that the data do not support its use.

两项 III 期临床试验提供了相互矛盾的结果，美国食品和药物管理局召集的独立顾问小组评估该药物的有效性表示， 数据不支持其使用。